And when you look at the Zenith slides from Biotech Showcase, it really helps to have Masila's transcript from the January 7th, 2016 Zenith AGM handy. One thing I noticed is that the slides from the Biotech Showcase lack anything to do with the Zenith Capital Corp/Zenith Epigenetics Limited/Royalty stream. So we don't have any slides on that and will have to rely on what Masila and Fouremm had posted.

The Q&A from Masila's transcript also does a great job of describing the near term goals of Zenith. In particular, it sounds like Zenith and pharmaceutical companies are very excited to see the Phase I results of ZEN-3694 in humans. To quote Masila's transcript "Key is to focus on and get this first Proof of Concept done to prove our approach - then the floodgates will open." As discussed on this board earlier, Masila's transcript also noted that Clinical Trial will start this quarter, meaning Q1 2016 or by end of March 2016. Very exciting.

Have a great weekend,

BearDownAZ